More obese participants lost 26.5 per cent, and unusually every single participant shed at least five per cent of their body weight
I found that people who go this route often do so because they feel the clinical trial path is too slow or they do not qualify
Back Madsen, OD, Karlsen, C, Blume, N, et al (1995) 'Transplantable glucagonomas derived from pluripotent rat islet tumor tissue cause severe anorexia and adipsia', Scandinavian Journal of Clinical and Laboratory Investigation Supplement , 220, 27-35
Results at 36 weeks by dose group: The critical finding: the proportion of lean mass loss to total weight loss was comparable to other obesity medications
GLP-1 Medicaid Coverage by State Despite some states offering limited coverage of GLP-1s to treat weight loss as far back as a decade ago, most states that currently provide coverage through taxpayer-funded Medicaid programs or state employee health plans have only opted to do so within the past five years
Inject into the subcutaneous tissue of the middle third of the thigh, roughly midway between the knee and hip, on the front or outer side
